Libra Therapeutics
PrivateLast Round
Grant
Dec 20, 2024
Total Funding Raised
$34M
Company Overview
Libra Therapeutics is a biotechnology company that develops novel disease-modifying therapeutics to restore cellular homeostasis and slow the progression of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Libra Therapeutics Comparables
Compare Libra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Casma Therapeutics | 90% | |
| Nine Square Therapeutics | 89% | |
| Lysoway Therapeutics | 87% | |
Libra Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 20, 2024 | ||||
| Series A | Sep 23, 2020 |
Key People
Founding team and executive leadership
Libra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sixty Degree Capital | Series A |
| Boehringer Ingelheim | Series A |
| Dolby Family Ventures | Series A |
| Epidarex Capital | Series A |
| Santé Ventures | Series A |
| Boehringer Ingelheim Venture Fund | Series A |
Libra Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Libra Therapeutics's valuation, stock price, and market status.